|
Age
|
86 (82–91)
|
87 (82–91)
|
86 (82–93)
|
0.815
|
|
Male sex
|
41.6% (52)
|
36.1% (35)
|
60.7% (17)
|
0.029
|
|
Admission from:
| | | |
0.663
|
|
Home
|
59.2% (74)
|
57.7% (56)
|
64.3% (18)
| |
|
Long-term care facility
|
40.8% (51)
|
42.3% (41)
|
35.7% (10)
| |
|
Medical history
|
|
Comorbidities
|
91.2% (114)
|
91.8% (89)
|
89.3% (25)
|
0.709
|
|
> 2 Comorbidities
|
67.2% (84)
|
67.0% (65)
|
67.9% (19)
|
0.822
|
|
Charlson Comorbidity Index
|
6 (5–7)
|
6 (5–7)
|
6 (5–7)
|
0.292
|
|
Neurological status
|
|
Etiologies of dementia
|
|
Unspecified cognitive impairment
|
60.0% (75)
|
59.8% (58)
|
60.7% (17)
|
1.000
|
|
Diagnosed dementia
|
40.0% (50)
|
40.2% (39)
|
39.3% (11)
|
1.000
|
|
Alzheimer’s disease
|
10.4% (13)
|
11.3% (11)
|
7.1% (2)
|
0.731
|
|
Vascular dementia
|
7.2% (9)
|
6.2% (6)
|
10.7% (3)
|
0.418
|
|
Other causes of dementia
|
7.2% (9)
|
5.2% (5)
|
14.3% (4)
|
0.113
|
|
Parkinson disease, parkinsonian syndromes
|
9.6% (12)
|
10.3% (10)
|
7.1% (2)
|
1.000
|
|
Psychosis
|
3.2% (4)
|
4.1% (4)
|
0.0% (0)
|
1.000
|
|
Alcohol-related dementia
|
2.4% (3)
|
3.1% (3)
|
0.0% (0)
|
1.000
|
|
Neurological symptoms and history
|
|
Mood disorder
|
31.2% (39)
|
33.0% (32)
|
25.0% (7)
|
0.640
|
|
Psychotic symptoms
|
12.0% (15)
|
12.4% (12)
|
10.7% (3)
|
1.000
|
|
History of stroke
|
32.0% (40)
|
32.0% (31)
|
32.1% (9)
|
1.000
|
|
History of fall
|
38.4% (48)
|
36.1% (35)
|
46.4% (13)
|
0.373
|
|
Walking before admission
|
70.4% (88)
|
70.1% (68)
|
71.4% (20)
|
1.00
|
|
Psychotropic treatment
|
60.0% (75)
|
60.8% (59)
|
57.1% (16)
|
0.826
|
|
Anxiolytic
|
30.4% (38)
|
32.0% (31)
|
25.0% (7)
|
0.642
|
|
Antidepressant, mood regulator
|
35.2% (44)
|
35.1% (34)
|
35.7% (10)
|
1.000
|
|
Neuroleptics
|
12.0% (15)
|
11.3% (11)
|
14.3% (4)
|
0.742
|
|
Non-neurological comorbidities
|
|
Cardiovascular disease
|
40.8% (51)
|
38.1% (37)
|
50.0% (14)
|
0.383
|
|
Arterial hypertension
|
80.0% (100)
|
79.4% (77)
|
82.1% (23)
|
1.00
|
|
Hypercholesterolaemia
|
48.8% (61)
|
46.4% (45)
|
57.1% (16)
|
0.392
|
|
Atrial fibrillation
|
24.8% (31)
|
24.7% (24)
|
25.0% (7)
|
1.00
|
|
Coronaropathy
|
16.0% (20)
|
14.4% (14)
|
21.4% (6)
|
0.388
|
|
Cardiac insufficiency
|
24.0% (30)
|
25.8% (25)
|
17.9% (5)
|
0.460
|
|
Thrombosis
|
9.6% (12)
|
11.3% (11)
|
3.6% (1)
|
0.296
|
|
COPD
|
8.8% (11)
|
6.2% (6)
|
17.9% (5)
|
0.068
|
|
Respiratory insufficiency
|
3.2% (4)
|
3.1% (3)
|
3.6% (1)
|
1.000
|
|
Diabetes
|
16.8% (21)
|
15.5% (15)
|
21.4% (6)
|
0.566
|
|
Malnutrition
|
33.6% (42)
|
37.1% (36)
|
21.4% (6)
|
0.172
|
|
Malignancy
|
9.6% (12)
|
11.3% (11)
|
3.6% (1)
|
0.296
|
|
Chronic liver disease
|
1.6% (2)
|
2.1% (2)
|
0.0% (0)
|
1.000
|
|
Chronic renal disease
|
16.0% (20)
|
11.3% (11)
|
32.1% (9)
|
0.017
|
